Collegium Pharmaceutical, Inc.

{
  "main_header": {
    "sid": 1241315,
    "name": "Collegium Pharmaceutical, Inc.",
    "stock_name": "Collegium Pharmaceutical, Inc.",
    "full_name": "Collegium Pharmaceutical, Inc.",
    "name_url": "stocks-analysis/collegium-pharmaceutical-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "48.18",
    "chg": 0.67,
    "chgp": "1.41%",
    "dir": 1,
    "prev_price": "47.51",
    "mcapval": "1,486.03",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US19459J1043",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "499.21 k",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/collegium-pharmaceutical-inc-1241315-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Collegium Pharmaceutical Hits New 52-Week High at $43.06",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/collegium-pharmaceutical-hits-new-52-week-high-at-4306-3686432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CollegiumPharma_priceRelatedfactors_3686432.png",
        "date": "2025-11-10 17:09:58",
        "description": "Collegium Pharmaceutical, Inc. achieved a new 52-week high, reflecting strong performance in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 1,222 million, the company shows effective management through a return on equity of 23.11%, despite a higher reliance on debt financing and no dividend offerings."
      },
      {
        "title": "Collegium Pharmaceutical, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/collegium-pharmaceuticals-valuation-grade-changes-from-expensive-to-fair-amid-stock-price-increase-3686318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CollegiumPharma_valuationdot_3686318.png",
        "date": "2025-11-10 16:12:28",
        "description": "Collegium Pharmaceutical, Inc. has adjusted its valuation, showcasing a favorable P/E ratio of 15 and strong profitability metrics, including a ROCE of 16.93% and ROE of 28.03%. The company has outperformed the S&P 500 in stock returns over both year-to-date and annual periods, highlighting its competitive market position."
      }
    ],
    "total": 20,
    "sid": "1241315",
    "stock_news_url": "https://www.marketsmojo.com/news/collegium-pharmaceutical-inc-1241315"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Collegium Pharmaceutical Hits New 52-Week High at $43.06

2025-11-10 17:09:58

Collegium Pharmaceutical, Inc. achieved a new 52-week high, reflecting strong performance in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 1,222 million, the company shows effective management through a return on equity of 23.11%, despite a higher reliance on debt financing and no dividend offerings.

Read full news article

Collegium Pharmaceutical, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Performance Metrics

2025-11-10 16:12:28

Collegium Pharmaceutical, Inc. has adjusted its valuation, showcasing a favorable P/E ratio of 15 and strong profitability metrics, including a ROCE of 16.93% and ROE of 28.03%. The company has outperformed the S&P 500 in stock returns over both year-to-date and annual periods, highlighting its competitive market position.

Read full news article

View All News